Skip to main content

UBS Group AG

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1610520 ZURICH, V8

Position in DNTH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$111,152,543
+$45,587,359 QoQ
Shares Held
1,140,260
+45.9% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 269 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. DNTH ranks #19 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $111,152,543 1,140,260
2026-03-31 $65,565,184 781,282
2025-12-31 $24,998,809 606,620
2025-09-30 $5,393,822 137,073
2025-06-30 $2,449,490 131,481
2025-03-31 $860,361 47,429
2024-12-31 $1,174,169 53,861
2024-09-30 $778,358 28,428
2024-06-30 $217,624 8,409
2024-03-31 $435,150 14,505
2023-12-31 $3,952 380
2023-09-30 $4,359 319
2023-06-30 MGTA 11,177
2023-03-31 MGTA 2,797
2022-09-30 MGTA 8,264
2021-12-31 MGTA 7,222
2021-09-30 MGTA 37
2021-06-30 MGTA 157
2021-03-31 MGTA 1,399
2020-12-31 MGTA 4,232